Skip to main content
BioInfra Co.,Ltd. logo

BioInfra Co.,Ltd. — Investor Relations & Filings

Ticker · 199730 ISIN · KR7199730003 KO Professional, scientific and technical activities
Open in API
Filings indexed 88 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 199730

About BioInfra Co.,Ltd.

http://bioinfra.co.kr/?lang=en

BioInfra Co., Ltd. is a biotechnology and healthcare company specializing in innovative solutions for disease prevention and early detection, with a primary focus on oncology. The company's core technology is a proprietary multi-biomarker blood test for the early screening of eight major cancers, including lung, liver, stomach, colorectal, prostate, breast, pancreatic, and ovarian cancer. This in vitro diagnostic tool analyzes a small blood sample to assess cancer risk, aiming to improve patient outcomes through early intervention. Beyond diagnostics, BioInfra also engages in pharmaceutical research and development, offering clinical research services and developing cancer gene treatments.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is the company's full quarterly report (“분기보고서”) for the period January 1 to March 31, 2026. It contains substantive financial statements, management’s analysis, audit opinion, detailed schedules, and other disclosures typical of a comprehensive interim report. It is not merely an announcement or certification, but the actual report itself. Therefore, it should be classified as an Interim/Quarterly Report. Q1 2026
2026-05-15 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is the official announcement of the results of the company’s Annual General Meeting held on March 25, 2026 (‘정기주주총회결과’), detailing approved agenda items (financial statements approval, dividend resolution, board composition, etc.) and vote counts/percentages. This matches the definition for Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-03-25 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 88% confidence The document is a formal ‘주식매수선택권 부여에 관한 신고’ (notification of stock‐option grant) submitted to the Financial Services Commission/Korea Exchange. It details issuance of new shares under stock options, exercise conditions, grant date, basis in the articles of incorporation, and allotment numbers. This is not a management commentary, earnings release, or annual/interim report but a capital‐change notification. Therefore it best fits Share Issue/Capital Change (SHA).
2026-03-25 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 95% confidence The document is a regulatory filing in Korean titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is an amendment (정정신고) to a previous filing. It details changes to stock option grants, specifically the cancellation of previously granted options. This type of disclosure regarding share-based compensation and capital changes falls under the category of share issues or capital changes, as it relates to the potential issuance of new shares via stock options.
2026-03-19 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'Bioinfra' (주식회사 바이오인프라). It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements for the fiscal years 2024 and 2025. This document is a comprehensive financial report containing actual financial statements and audit opinions, which fits the definition of an Audit Report (AR). FY 2025
2026-03-17 Korean
감사보고서제출
Audit Report / Information Classification · 95% confidence The document is a formal regulatory filing titled 'Audit Report Submission' (감사보고서 제출) from Bioinfra. It provides the auditor's opinion (unqualified/proper), key financial data (assets, liabilities, revenue, profit/loss), and details regarding the audit process. While it contains financial data, it is a specific regulatory disclosure of the audit report results rather than the full 10-K annual report or a simple announcement of publication. Given the focus on the audit opinion and financial summary, it fits the 'Audit Report / Information' category. FY 2025
2026-03-16 Korean

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.